Healthcare provider profile · identity verified

Eric J Bush, MD

Internal Medicine · GT BARRINGTON, MA · NPI 1801987151

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	592	202
Rosuvastatin Calcium	Rosuvastatin Calcium	516	165
Amlodipine Besylate	Amlodipine Besylate	407	127
Levothyroxine Sodium	Levothyroxine Sodium	385	114
Lisinopril	Lisinopril	365	121
Metoprolol Succinate	Metoprolol Succinate	323	96
Omeprazole	Omeprazole	301	86
Losartan Potassium	Losartan Potassium	225	72
Ezetimibe	Ezetimibe	212	71
Albuterol Sulfate Hfa	Albuterol Sulfate	188	61
Eliquis	Apixaban	183	44
Lorazepam	Lorazepam	177	58
Metformin Hcl	Metformin Hcl	165	52
Trazodone Hcl	Trazodone Hcl	164	49
Tamsulosin Hcl	Tamsulosin Hcl	163	51
Escitalopram Oxalate	Escitalopram Oxalate	151	47
Gabapentin	Gabapentin	151	42
Zolpidem Tartrate	Zolpidem Tartrate	145	37
Furosemide	Furosemide	144	50
Hydrochlorothiazide	Hydrochlorothiazide	137	44
Xarelto	Rivaroxaban	128	30
Doxycycline Hyclate	Doxycycline Hyclate	116	86
Prednisone	Prednisone	116	60
Duloxetine Hcl	Duloxetine Hcl	111	27
Pantoprazole Sodium	Pantoprazole Sodium	106	36
Tramadol Hcl	Tramadol Hcl	101	34
Azithromycin	Azithromycin	98	60
Famotidine	Famotidine	91	31
Fluticasone Propionate	Fluticasone Propionate	91	37
Sertraline Hcl	Sertraline Hcl	91	28
Allopurinol	Allopurinol	90	30
Clonazepam	Clonazepam	87	28
Simvastatin	Simvastatin	85	29
Alprazolam	Alprazolam	84	31
Celecoxib	Celecoxib	83	30
Potassium Chloride	Potassium Chloride	83	29
Clopidogrel	Clopidogrel Bisulfate	82	21
Valsartan	Valsartan	78	23
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	77	57
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	77	22
Finasteride	Finasteride	76	22
Meloxicam	Meloxicam	76	28
Synthroid	Levothyroxine Sodium	74	23
Bupropion Xl	Bupropion Hcl	73	26
Pravastatin Sodium	Pravastatin Sodium	71	23
Diazepam	Diazepam	68	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	68	13
Irbesartan	Irbesartan	67	23
Metoprolol Tartrate	Metoprolol Tartrate	63	25
Mounjaro	Tirzepatide	61	suppressed
Ozempic	Semaglutide	61	11
Ibuprofen	Ibuprofen	58	21
Paxlovid	Nirmatrelvir/Ritonavir	57	56
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	34
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	52	39
Jardiance	Empagliflozin	51	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	16
Alendronate Sodium	Alendronate Sodium	49	17
Repatha Sureclick	Evolocumab	49	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	48	18
Chlorthalidone	Chlorthalidone	46	16
Metformin Hcl Er	Metformin Hcl	45	17
Insulin Lispro Kwikpen U-100	Insulin Lispro	42	suppressed
Citalopram Hbr	Citalopram Hydrobromide	41	12
Januvia	Sitagliptin Phosphate	41	suppressed
Testosterone	Testosterone	41	suppressed
Glimepiride	Glimepiride	40	suppressed
Ramipril	Ramipril	40	11
Donepezil Hcl	Donepezil Hcl	38	12
Propranolol Hcl Er	Propranolol Hcl	38	suppressed
Nicotrol Ns	Nicotine	35	suppressed
Valacyclovir	Valacyclovir Hcl	35	16
Warfarin Sodium	Warfarin Sodium	35	14
Folic Acid	Folic Acid	34	suppressed
Montelukast Sodium	Montelukast Sodium	34	13
Nifedipine Er	Nifedipine	34	11
Torsemide	Torsemide	34	11
Temazepam	Temazepam	33	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	31	suppressed
Farxiga	Dapagliflozin Propanediol	30	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	30	suppressed
Topiramate	Topiramate	30	suppressed
Atenolol	Atenolol	29	12
Dutasteride	Dutasteride	29	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Pregabalin	Pregabalin	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Ketoconazole	Ketoconazole	28	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Myrbetriq	Mirabegron	28	suppressed
Nebivolol Hcl	Nebivolol Hcl	28	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	28	suppressed
Fenofibrate	Fenofibrate	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	20
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Spironolactone	Spironolactone	26	12
Carisoprodol	Carisoprodol	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Amoxicillin	Amoxicillin	24	13
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	24	15
Niacin Er	Niacin	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Oxycodone Hcl	Oxycodone Hcl	24	13
Ventolin Hfa	Albuterol Sulfate	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Colchicine	Colchicine	23	suppressed
Eplerenone	Eplerenone	23	suppressed
Labetalol Hcl	Labetalol Hcl	23	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	23	suppressed
Carvedilol	Carvedilol	22	12
Clobetasol Propionate	Clobetasol Propionate	22	17
Eszopiclone	Eszopiclone	22	suppressed
Lamotrigine	Lamotrigine	22	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Mupirocin	Mupirocin	21	16
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	20	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	20	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Cefuroxime	Cefuroxime Axetil	18	suppressed
Liothyronine Sodium	Liothyronine Sodium	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	15
Estradiol	Estradiol	17	suppressed
Lidocaine	Lidocaine	17	suppressed
Naproxen	Naproxen	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Praluent Pen	Alirocumab	16	suppressed
Ativan	Lorazepam	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Linzess	Linaclotide	13	suppressed
Mesalamine Er	Mesalamine	13	suppressed
Vascepa	Icosapent Ethyl	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Prempro	Estrogen,con/M-Progest Acet	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Digoxin	Digoxin	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Erythromycin	Erythromycin Base	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error